Atlas Trials

Stage II Bladder Cancer AJCC v8

16 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage II Bladder Cancer AJCC v8

RecordFirmDate
Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer (NCT04383743)University of Washington2020-11-24
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes (NCT04501913)City of Hope Medical Center2019-12-24
Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer (NCT03775265)National Cancer Institute (NCI)2019-06-03
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study (NCT06350734)Mayo Clinic2018-10-12
Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer (NCT03617913)Mayo Clinic2018-09-19
Pembrolizumab in Treating Patients With Bladder Cancer Undergoing Radical Cystectomy (NCT03319745)M.D. Anderson Cancer Center2018-01-11
Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer (NCT00749892)M.D. Anderson Cancer Center2008-06-10

Track Stage II Bladder Cancer AJCC v8 automatically

Every clearance here is in the API, with alerts when new ones post.